Onxeo S.A. announced the appointment of Dr. Robert L. Coleman and Dr. Jacques Mallet as independent members of the Board of Directors. Robert L. Coleman, MD, is the Chief Scientific Officer of US Oncology Network. Prior to joining the US Oncology Network in 2020, Dr. Coleman served as executive director of MD Anderson's Cancer Network Research Program. Jacques Mallet, MD, served as SVP - Head of Portfolio Analytics/Corporate Strategy and Member of the Executive Leadership Team of Sanofi and is currently board member of several listed or private companies in the health technology sector.